Policies & Publications: Medicine Guidelines

Title Document Number Last Reviewed
Acetylcysteine IV in Acute Paracetamol Overdose SESLHDPR/566
Acetylcysteine IV in non-paracetamol induced acute liver injury failure
Adenosine Protocol – Antiarrhythmic SESLHDPR/583
Agomelatine in major depression SESLHDPR/646
Andexanet Alfa SESLHDMG/101
Argatroban for Heparin Induced Thrombocytopenia (HIT) SESLHDPR/719
Aspirin IV in Neurointerventional Procedures and Intensive Care Areas
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis
Bedaquiline fumarate for resistant pulmonary tuberculosis
Belatacept for prophylaxis of organ rejection in adult patients receiving/received a kidney transplant SESLHDPR/751
Bivalirudin for Heparin induced thrombocytopenia (HIT) SESLHDPR/711
Colistimethate (Colistin) IV (Polymyxin E) for Urinary Tract Infections SESLHDPR/608
Danaparoid
Dinoprostone SESLHDPR/568
Direct Oral Anticoagulants - DOAC Guidelines - CEC
Empaglifozin for Type 2 Diabetes SESLHDPR/599
Entecavir for HBV reactivation in Renal Patients SESLHDPR/726
Fentanyl 2 microg/mL with Adrenaline (epinephrine) 2 microg/mL and Bupivacaine 0.1% epidural infusion
Ferric Carboxymaltose (Ferinject) - Iron
Ferric Derisomaltose (Monofer)
Fomepizole for treatment of toxic alcohol (methanol, ethylene glycol) poisoning
Fondaparinux for Heparin induced Thrombocytopenia (HIT)
Fosfomycin Oral Prescribing Protocol SESLHDPR/661
Heparin - Anticoagulation with Intravenous Heparin Sodium Infusion

SESLHDPR/402
Idarucizumab in Urgent Dabigatran Reversal SESLHDPR/571
Insulin dextrose infusion in Pregnancy RHW SESLHDMG/103
Insulin Glargine High Concentration 300 units/mL (Toujeo®)
Iron Infusions

Medicine Guidelines:

SESLHDPR/753
Iron Polymaltose (Ferrosig)
Iron Sucrose (Venofer)
Lamotrigine for use in Spinal Cord Injury Induced Neuropathic Pain OR for Intractable Trigeminal Neuralgia
Levosimendan SESLHDPR/725
Lidocaine (lignocaine) patch for symptomatic treatment of neuropathic pain refractory or unsuitable for alternative medications SESLHDPR/648
Meglumine Diatrizoate and Sodium Diatrizoate (Gastrografin®) in Adult Adhesional Small Bowel Obstruction SESLHDPR/570
Methotrexate (oral) SESLHDMG/102
Methoxyflurane Inhaler for Acute Pain Management
Naloxone for treatment of opioid induced over-sedation and respiratory depression
Naltrexone for treatment of long-acting opioid poisoning SESLHDPR/651
Natalizumab
Ocrelizumab for Multiple Sclerosis SESLHDPR/629
Olanzapine Pamoate Long-Acting Injection (LAI)
Pain Management- Ketamine Infusions for Adult Patients with Acute and Chronic Non- Cancer Pain
Paracetamol
Phentolamine in the treatment of dermal necrosis or sloughing following extravasation of peripherally administered noradrenaline (norepinephrine)
Polymyxin B IV for infections outside of the urinary tract SESLHDPR/573
Rituximab
Sacubitril+Valsartan (Entresto®) for Systolic Heart Failure SESLHDPR/585
Sodium Thiosulfate in Calciphylaxis SESLHDPR/659
Subcutaneous Furosemide for end stage heart failure with fluid overload in the dying patient
Subcutaneous Ketamine for Refractory Neuropathic Pain in the Palliative Care Setting
Subcutaneous levetiracetam for seizure management in palliative care patients
Subcutaneous levomepromazine for refractory nausea in the palliative care patient and agitation in the terminal phase
Subcutaneous lidocaine for refractory neuropathic pain in the palliative care setting
Subcutaneous phenobarbital for refractory terminal agitation and uncontrolled seizure (including status epilepticus) in the imminently dying patient
Tapentadol in Moderate to Severe Pain SESLHDPR/587
Ticagrelor – Prevention of thrombotic complications post neurointerventional stenting procedures SESLHDPR/673
Tirofiban in emergency interventional neuroradiology procedures
Tolvaptan in inpatient treatment of hyponatraemia SESLHDPR/576
Ulipristal Acetate for Emergency Contraception SESLHDPR/619
Ustekinumab for Crohn's Disease SESLHDPR/611
Varenicline for smoking cessation SESLHDPR/649
Zoledronic Acid for Early/Locally Advanced Breast Cancer
Zoledronic Acid in the treatment of Osteoporosis with fracture due to minimal trauma SESLHDPR/720